ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NIVEA RIBAS M D

Neurology

16,047

$2.17M

1483
1322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$135
Average prescription price

Avg: $204

RICARDO PLASENCIA M.D.

Neurology

15,608

$1.72M

1642
1546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$110
Average prescription price

Avg: $204

HECTOR LALAMA MD PA

Neurology

14,473

$897K

343
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $204

JUAN SIMON MD

Neurology

11,530

$762K

1208
1158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

1%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $204

JOHN CINTRON M.D

Neurology

9,049

$901K

1545
1348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$100
Average prescription price

Avg: $204

ACHRAF MAKKI M.D.

Neurology

9,004

$1.13M

771
340 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

43%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $204

CARLOS GARCIA-RIVERA D.O.

Neurology

8,699

$1.35M

1030
935 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$156
Average prescription price

Avg: $204

FERNANDO GONZALES-PORTILLO MD

Neurology

8,329

$1.18M

1111
701 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$142
Average prescription price

Avg: $204

LANCE KIM D.O.

Neurology

7,361

$3.27M

827
411 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$444
Average prescription price

Avg: $204

KARIN MADDOX M.D.

Neurology

6,984

$604K

557
256 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

41%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$86
Average prescription price

Avg: $204

THOMAS DIGERONIMO M.D.

Neurology

6,944

$846K

626
209 are 65+

28%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $204

GILBERTO CRUZ M.D.

Neurology

6,651

$773K

648
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$116
Average prescription price

Avg: $204

LISA BANCHIK M.D.

Neurology

6,075

$984K

194
89 are 65+

60%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$162
Average prescription price

Avg: $204

GARY WEISS MD

Neurology

5,931

$978K

534
174 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$165
Average prescription price

Avg: $204

ARASTOO NABIZADEH MD

Neurology

5,753

$727K

250
106 are 65+

54%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $204

JOHN ORTOLANI M.D.

Neurology

5,576

$491K

525
162 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

56%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $204

DIEGO RIELO MD

Neurology

5,512

$752K

720
621 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$136
Average prescription price

Avg: $204

ERASMO PASSARO M.D.

Neurology

5,391

$1.23M

383
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$227
Average prescription price

Avg: $204

JOSSE MAZO-MAYORQUIN M.D.

Neurology

5,350

$542K

519
340 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$101
Average prescription price

Avg: $204

ALYN BENEZETTE D.O.

Neurology

5,007

$866K

423
134 are 65+

53%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$173
Average prescription price

Avg: $204

JOSE GAUDIER MD

Neurology

5,006

$1.21M

707
550 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$242
Average prescription price

Avg: $204

AMUDHA PERUMAL M.D

Neurology

4,989

$584K

387
191 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$117
Average prescription price

Avg: $204

CARLOS SINGER

Neurology

4,865

$1.25M

337
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$257
Average prescription price

Avg: $204

LINDA PAO MD

Neurology

4,783

$880K

505
456 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$184
Average prescription price

Avg: $204

JOHN WILSON M.D.

Neurology

4,770

$539K

463
322 are 65+

29%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank